glp 1 medi cal coverage Opinion: GLP-1 drugs aren't just cosmetic; Medi-Cal must cover them Doctors call Ozempic a miracle

Efficacy and safety of lixisenatide once daily versus exenatide twice daily in type 2 diabetes inadequately controlled on metformin: a 24-week, randomized, open-label, active-controlled study (GetGoal-X)

Whilst Wegovy is not designed to treat ADHD, some patients and clinicians have observed potential indirect effects on certain ADHD-related behaviours

Unlike branded pens, which are designed for a degree of temperature fluctuation, compounded vials are often more stable when kept consistently cold

In company-reported late-phase maintenance data, patients in SURMOUNT-MAINTAIN first lost weight on higher-dose Zepbound, then either continued the maximum tolerated dose or stepped down to 5 mg for a maintenance year

Amato L, Paolisso G, Cacciatore F, Ferrara N, Ferrara P, Canonico S, et al